Massachusetts Hospital Utilizes New Method for Detecting Colorectal Cancer

Quincy (Mass.) Medical Center has been tapped to conduct a new clinical trial that would assess the efficacy of a GI device aimed at detecting more abnormalities during colonoscopy, according to a Boston Globe news report.

Advertisement

The Third Eye device enables GI physicians to view a 360-degree image of patients’ colons, which reduces the risk of missing colorectal polyps. The device, which is FDA approved, is contained within a traditional colonoscopy but allows physicians to view up to 25 percent more colon abnormalities than a routine colonoscopy, according to the news report.

Read the news report about use of the Third Eye device at Quincy Medical Center.

Read other coverage about colonoscopy:

Detection of Premalignant Colon Polyps Stable Throughout Workday Under Certain Conditions

Position Changes During Colonoscope Withdrawal Can Increase Adenoma Detection Rate

Study: Polypectomy Rate Can Be Used as Quality Measure

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.